$0.0751
0.004806.83%
Pre-Market: Mar 24, 4:00 PM EDT
Comments
Loading...
MediPharm Labs Analyst Ratings and Price Targets | OTC:MEDIF | Benzinga
MediPharm Labs Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for MediPharm Labs Corp from these most-recent analyst ratings.
Analyst Ratings for MediPharm Labs
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for MediPharm Labs (MEDIF) stock?
There is no price target for MediPharm Labs
What is the most recent analyst rating for MediPharm Labs (MEDIF)?
There is no analyst for MediPharm Labs
When was the last upgrade for MediPharm Labs (MEDIF)?
There is no last upgrade for MediPharm Labs
When was the last downgrade for MediPharm Labs (MEDIF)?
There is no last downgrade for MediPharm Labs.
When is the next analyst rating going to be posted or updated for MediPharm Labs (MEDIF)?
There is no next analyst rating for MediPharm Labs.
Is the Analyst Rating MediPharm Labs (MEDIF) correct?
There is no next analyst rating for MediPharm Labs.
Browse analyst ratings and price targets on all stocks.